Natural Biocon
4.20
0.00(0.00%)
Market Cap₹10.80 Cr
PE Ratio-70.00
IndustryChemicals
Company Performance:
1D0.00%
1M+0.72%
6M-54.40%
1Y-70.46%
5Y-74.31%
View Company Insightsright
More news about Natural Biocon
24Apr 25
Biocon Unveils Ambitious 45 Billion Rupee Fundraising Plan Amid Financial Growth
Biocon, a leading biopharmaceutical company, plans to raise up to ₹45 billion ($540 million) through securities issuance, potentially via QIP or other methods. This move comes as the company experiences significant asset growth but faces increased liabilities and cash flow challenges. Recent financial data shows a 24.44% increase in total assets and a 145.45% rise in current assets, alongside a 238.46% surge in current liabilities. The company's cash flow from operating activities has turned negative, shifting from ₹0.20 billion to -₹0.10 billion year-over-year.
 no imag found
Natural Biocon
4.20
0.0
(0.0%)
1 Year Returns:-70.46%
Industry Peers
UPL
724.30
(-2.77%)
PI Industries
3,150.60
(-2.23%)
Bayer Crop Science
4,791.20
(-0.86%)
Sumitomo Chemical
407.05
(-1.63%)
Sharda Cropchem
1,256.00
(+0.27%)
Rallis
264.40
(-1.16%)
Dhanuka Agritech
1,123.50
(-0.40%)
NACL Industries
140.65
(-4.02%)
Bharat Rasayan
1,670.50
(-4.30%)